bioAffinity Technologies, Inc. (BIAF) Debt Components
- 2026-06-30: Short-term DebtUSD (m); Notes Payable, CurrentUSD $22.56K; Debt Instrument, Interest Rate, Stated Percentagepure (m); Debt Instrument, Periodic PaymentUSD (m).
- 2026-03-31: Short-term DebtUSD (m); Notes Payable, CurrentUSD $61.14K; Debt Instrument, Interest Rate, Stated Percentagepure (m); Debt Instrument, Periodic PaymentUSD (m).
- 2025-12-31: Short-term DebtUSD (m); Notes Payable, CurrentUSD $105.16K; Debt Instrument, Interest Rate, Stated Percentagepure (m); Debt Instrument, Periodic PaymentUSD (m).
- 2025-09-30: Short-term DebtUSD (m); Notes Payable, CurrentUSD (m); Debt Instrument, Interest Rate, Stated Percentagepure (m); Debt Instrument, Periodic PaymentUSD 1 month · $24.00K.
bioAffinity Technologies, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Short-term Debt USD | Notes Payable, Current USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Periodic Payment USD | Convertible Notes Payable, Current USD | Debt Instrument, Face Amount USD | Debt Instrument, Convertible, Beneficial Conversion Feature USD | Debt Instrument, Convertible, Conversion Price USD/shares |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $22.56K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $61.14K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $105.16K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | (m) | (m) | 1 month · $24.00K | (m) | (m) | (m) | (m) |
| 2025-09-30 | $260.00K | (m) | 6.70% | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $136.40K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $32.95K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $104.77K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $171.67K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | 1 month · $13.00K | (m) | (m) | (m) | (m) |
| 2024-09-30 | $127.50K | (m) | 11.64% | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $267.08K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $4.11K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $4.69K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $500.00K | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 4.20 |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $400.00K | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | $325.00K | $9.41M | (m) | (m) |
| 2022-08-11 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 4.20 |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $700.00K | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | $11.15M | $8.78M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |